Entecavir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Entecavir
Health Canada Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Entecavir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 18 USDMF, 9 CEP/COS, 11 JDMF, 4 EU WC, 13 KDMF, 10 NDC API, 27 Listed Suppliers, $ API Reference Price

42 API Suppliers
18 USDMF
9 CEP/COS
11 JDMF
4 EU WC
13 KDMF
10 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

135 FDF Dossiers, 39 FDA Orange Book, 42 Europe, 7 Canada, 13 Australia, 2 South Africa, 32 Listed Dossiers

135 FDF Dossiers
39 FDA Orange Book
42 Europe
7 Canada
13 Australia
2 South Africa
32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, SOLUTION;ORAL - 0.05MG/ML

TABLET;ORAL - 0.5MG
TABLET;ORAL - 1MG
SOLUTION;ORAL - 0.05MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 5 DKSH, 5 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 24 BASF, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 34 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Thickeners and Stabilizers, 30 Controlled & Modified Release, 26 Solubilizers, 24 Granulation, 20 Taste Masking, 19 Chewable & Orodispersible Aids, 17 Parenteral, 16 Lubricants & Glidants, 16 Film Formers & Plasticizers, 16 Topical, 15 Co-Processed Excipients, 8 Emulsifying Agents, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents

81 Fillers, Diluents & Binders
54 Coating Systems & Additives
34 Disintegrants & Superdisintegrants
34 Direct Compression
32 Thickeners and Stabilizers
30 Controlled & Modified Release
26 Solubilizers
24 Granulation
20 Taste Masking
19 Chewable & Orodispersible Aids
17 Parenteral
16 Lubricants & Glidants
16 Film Formers & Plasticizers
16 Topical
15 Co-Processed Excipients
8 Emulsifying Agents
6 API Stability Enhancers
6 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 25 News #PharmaBuzz

1 Data Compilation #PharmaFlow
25 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 36 Regulatory FDF Prices, 7 Annual Reports

2 US Medicaid Prescriptions
36 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

12 APIs, 7 FDF Dossiers

12 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 3 USP, 3 Others

1 EDQM
3 USP
3 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 220,091 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gowling Lafleur Henderson LLP

filter Patent Reset all filters

2 All

01 22053339

filter Product Reset all filters

2 All

01 2Entecavir

filter Dosage Reset all filters

2 All

01 1Oral Solution

02 1Tablet

filter Exp Date Reset all filters

2 All

01 22011-10-11

Product Main Page

01

Gowling Lafleur Henderson LLP

Entecavir

Immuno-Oncology 360

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-10-11

Date Granted : 2001-05-29

Brand Name : BARACLUDE

Patent Number : 2053339

Filing Date : 1991-10-11

Strength per Unit : 0.05 mg / ml

Dosage Form : Oral Solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-10-11

Date Granted : 2001-05-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Entecavir

Immuno-Oncology 360

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-10-11

Date Granted : 2001-05-29

Brand Name : BARACLUDE

Patent Number : 2053339

Filing Date : 1991-10-11

Strength per Unit : 0.5 mg / tablet

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-10-11

Date Granted : 2001-05-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!